Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Alere Scarborough, Inc.

US

Last updated May 25, 2026

What Alere Scarborough, Inc. makes

Alere Scarborough, Inc. manufactures rapid in vitro diagnostic (IVD) tests for self-testing and clinical use, including antigen kits for SARS-CoV-2, respiratory viruses, and malaria. Their portfolio also includes isothermal nucleic acid amplification analysers for laboratory testing, photometric/spectroscopic immunoassay analysers, and rapid immunochromatographic tests (ICT) for RSV, Group A Streptococcus, and Legionella urinary antigen detection.

The company’s devices are regulated under FDA classifications including Class I, Class II, Class III, and non-classified (N) products, with submissions recorded in the FDA’s 510(k) and UDI registries. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Alere Scarborough, Inc. primarily manufacture?

Alere Scarborough, Inc. specializes in rapid in vitro diagnostic (IVD) tests, including antigen kits for self-testing and clinical use. Their portfolio covers SARS-CoV-2 antigen tests, respiratory virus detection (such as RSV and influenza), malaria diagnostics, and rapid immunochromatographic tests (ICT) for conditions like Group A Streptococcus and Legionella. They also produce laboratory-grade devices like isothermal nucleic acid amplification analysers and photometric/spectroscopic immunoassay analysers.

Where is Alere Scarborough, Inc. based, and how does that affect its regulatory oversight?

Alere Scarborough, Inc. is based in the United States, which means its devices fall under FDA regulation. Since the U.S. is the manufacturer’s home country, their products are evaluated and authorised through the FDA’s regulatory pathways, including submissions recorded in the FDA’s 510(k) and Unique Device Identifier (UDI) registries.

Which regulatory registries list Alere Scarborough, Inc.’s devices, and why?

Alere Scarborough, Inc.’s devices are listed in the FDA’s 510(k) and UDI registries. The 510(k) registry tracks submissions for devices that require premarket notification to demonstrate substantial equivalence to a legally marketed predicate device, while the UDI registry ensures unique identification of medical devices for tracking and compliance purposes. These registries reflect the company’s adherence to FDA requirements for device authorisation.

How are Alere Scarborough, Inc.’s devices classified under FDA regulations?

Alere Scarborough, Inc.’s devices are classified under various FDA categories, including Class I (low-risk, general controls), Class II (moderate-risk, requiring special controls), Class III (high-risk, requiring premarket approval), and non-classified (N) products. The classification depends on factors like the device’s intended use, risk level, and regulatory history, ensuring appropriate oversight based on potential patient risk.

What distinguishes Alere Scarborough, Inc.’s rapid diagnostic tests from other similar products?

Alere Scarborough, Inc.’s rapid diagnostic tests are designed for quick, point-of-care or self-testing results, often using immunochromatographic technology (ICT) for ease of use in clinical or home settings. Many of their devices, like the BinaxNOW® series, are engineered for simplicity—requiring minimal training—while still delivering reliable detection for conditions like COVID-19, malaria, or RSV. Their laboratory-grade analysers, such as isothermal amplification systems, offer higher sensitivity for more complex diagnostic needs.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
154148498

Catalogue (134)

Page 2 of 3
DeviceModel / ReferenceRegistriesClassStatus
BinaxNOW Nasopharyngeal Swab Accessory Kit 400-065
FDA UDI
Class IActive
BinaxNOW COVID-19 Antigen Self Test 195-260
FDA UDI
NActive
BinaxNOW COVID-19/Flu A&B Combo Self Test 20002050
FDA UDI
Class IIActive
ID NOW™ Instrument EQ00200X
FDA UDI
Class IIActive
Alere Reader BinaxNOW Tray Pack LFR-004
FDA UDI
N/AActive
Alere Determine™ HIV–1/2 Ag/Ab Combo Controls 7D2628
FDA UDI
Class IIUnknown
BinaxNOW COVID-19 Antigen Self Test 195-170
FDA UDI
Class IIActive
Alere NMP22® Urine Collection Kit D2100E
FDA UDI
Class IIIActive
Alere Reader Calibration Check Card LFR-003
FDA UDI
N/AUnknown
BinaxNOW™ Legionella Control Swab Pack 852-010
FDA UDI
Class IIActive
ID NOW™ Instrument EQ00200XS
FDA UDI
Class IIActive
BinaxNOW COVID-19 Antigen Self Test 195-160
FDA UDI
Class IIActive
Alere™ i Instrument EQ00200XS
FDA UDI
Class IIActive
BinaxNOW COVID-19 Antigen Self Test 195-269
FDA UDI
NActive
Alere™ i Instrument EQ00200X
FDA UDI
Class IIActive
BinaxNOW COVID-19/Flu A&B Combo Self Test 295-364
FDA UDI
Class IIActive
Alere Reader EQ00600X
FDA UDI
N/AActive
Osteomark NTx Urine 9006
FDA UDI
Class IUnknown
NMP22 BladderChek Control Kit D1250
FDA UDI
Class IIActive
Alere™ i Strep A 733-000
FDA UDI
Class IIUnknown
Binax® Legionella EIA Wash Buffer Accessory Kit 851-100
FDA UDI
Class IIActive
BinaxNOW COVID-19 Antigen Self Test 195-264
FDA UDI
NActive
Fingerstick Sample Collection Kit 2604US199
FDA UDI
N/AUnknown
BinaxNOW Influenza A & B Card 2 Control Swab Kit 575-080
FDA UDI
Class IIActive
Alere i RSV 435-000
FDA UDI
Class IIUnknown
BinaxNOW COVID-19/Flu A&B Combo Self Test 20002051
FDA UDI
Class IIActive
BinaxNOW COVID-19 Antigen Self Test 195-270
FDA UDI
NActive
BinaxNOW® Malaria Positive Control Kit 665-010
FDA UDI
Class IActive
Id Now™ Covid-19 190-000
FDA UDI
NUnknown
BinaxNOW COVID-19 Ag Positive Control Swab Pack 195-080
FDA UDI
NActive
BinaxNOW Streptococcus pneumoniae Antigen Card 710-000
FDA UDI
Class IActive
ISOSTAT® Press and Rack 50C2
FDA UDI
Class IIUnknown
BinaxNOW COVID-19 Antigen Self Test 195-265
FDA UDI
NActive
BinaxNOW RSV 430-122
FDA UDI
Class IActive
Alere NMP22 BladderChek Control Kit D1250
FDA UDI
Class IIUnknown
BinaxNOW Strep A Card 730-025
FDA UDI
Class IActive
Clearview PBP2a SA Culture Colony Test 893-000
FDA UDI
Class IIActive
Alere i RSV Control Swab Kit 435-080
FDA UDI
Class IIUnknown
Alere NMP22 BladderChek Test D1200
FDA UDI
Class IIIUnknown
ID NOW Strep A 2 734-000
FDA UDI
Class IIActive
BinaxNOW COVID-19/Flu A&B Combo Self Test 295-363
FDA UDI
Class IIActive
Alere Determine™ HIV–1/2 Ag/Ab Combo 7D2648
FDA UDI
Class IIUnknown
Alere Influenza A & B Test 412-000
FDA UDI
Class IIUnknown
BinaxNOW Legionella Urinary Antigen Card 852-000
FDA UDI
Class IIActive
Alere Influenza A & B Control Swab Kit 412-080
FDA UDI
Class IIUnknown
BinaxNOW COVID-19/Flu A&B Combo Self Test 295-362
FDA UDI
Class IIActive
BinaxNOW COVID-19 Reagent Accessory Kit 195-090
FDA UDI
NActive
BinaxNOW RSV 430-022
FDA UDI
Class IActive
ID NOW Instrument NAT-024R
FDA UDI
Class IIActive
Alere BinaxNOW Influenza A & B Card 2 Control Swab Kit 575-080
FDA UDI
Class IIUnknown

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.